Peptide-based vectors have received notice for their specificity in binding to receptors overexpressed in breast cancer cells, potentially overcoming issues relevant to small internalization. These strategies open up new avenues for therapies customized to combat distinct breast cancer subtypes and glioblastoma by honing in on integrins, fibronectins, and matrix metalloproteinases. https://robertj321hkm4.wikigop.com/user